Eye Care Institute, A Medical Corporation in Santa Rosa, CA - Medicare Durable Medical Equipment & Medical Supplies Provider

Eye Care Institute, A Medical Corporation is a medicare enrolled "Durable Medical Equipment & Medical Supplies" provider in Santa Rosa, California. Their current practice location is 3035 Cleveland Ave Ste 100, Santa Rosa, California. You can reach out to their office (for appointments etc.) via phone at (707) 546-9800.

Eye Care Institute, A Medical Corporation is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Eye Care Institute, A Medical Corporation is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1083141857.

Contact Information

	Eye Care Institute, A Medical Corporation
	3035 Cleveland Ave Ste 100, Santa Rosa, CA 95403-3037
	(707) 546-9800
	Not Available

Healthcare Provider's Profile

Full Name	Eye Care Institute, A Medical Corporation
Type	Facility
Speciality	Durable Medical Equipment & Medical Supplies
Location	3035 Cleveland Ave Ste 100, Santa Rosa, California
Accepts Medicare Assignments	Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.

NPI Data:

NPI Number: 1083141857
Provider Enumeration Date: 05/11/2017
Last Update Date: 09/14/2023

Medicare PECOS Information:

PECOS PAC ID: 7315010766
Enrollment ID: O20170821000964

Medical Identifiers

Medical identifiers for Eye Care Institute, A Medical Corporation such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083141857	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	(* (Not Available))	Secondary
332B00000X	Durable Medical Equipment & Medical Supplies	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eye Care Institute, A Medical Corporation is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Eye Care Institute, A Medical Corporation 3035 Cleveland Ave Ste 100, Santa Rosa, CA 95403-2122 Ph: (707) 545-3800	Eye Care Institute, A Medical Corporation 3035 Cleveland Ave Ste 100, Santa Rosa, CA 95403-3037 Ph: (707) 546-9800

News Archive

Patients with stable vitiligo may achieve good repigmentation with skin transplants using skin taken from normally-pigmented areas of their own bodies

Patients with stable vitiligo, a skin disorder characterized by patches of lighter colored, or depigmented skin, may achieve good repigmentation of these areas with skin transplants using skin taken from normally-pigmented areas of their own bodies

Study analyzes link between clonal hematopoiesis and treatment-related blood cancer risk

In recent years, improvements in cancer therapy have led to a significant increase in cancer survivorship. Experts estimate that by 2022, the United States will have 18 million cancer survivors, but a subset of those survivors will have long-term health problems to be addressed.

A*STAR, GE Global Research join forces in integrated advanced medical imaging technologies

GE Global Research, the central technology development arm for GE Healthcare and all of GE's businesses, has signed a Memorandum of Understanding (MOU) with Singapore's Agency of Science, Technology and Research (A*STAR). This agreement will focus on advancing current medical imaging technologies and diagnostics to enable more accurate, earlier and faster clinical diagnoses of cancer and other diseases. The partnership between A*STAR and GE Global Research brings together two world-class research institutions, integrating their deep domain expertise in biomedical, science, and engineering capabilities to support this effort.

Cardiovascular adverse events linked to hydroxychloroquine and chloroquine

As the antimalarial drugs hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it's now more important than ever to have a thorough assessment of the safety of these medications.

Eye Care Institute, A Medical Corporation - Medicare in Santa Rosa, CA